These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22233400)

  • 21. [Interferon-alpha and PUVA therapy for mycosis fungoides].
    Marschalkó M; Kovács J; Somlai B; Berecz M; Hídvégi B; Hársing J; Désaknai M; Horváth A
    Orv Hetil; 2001 Sep; 142(37):2021-3. PubMed ID: 11582733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma.
    Spaccarelli N; Rook AH
    Dermatol Clin; 2015 Oct; 33(4):731-45. PubMed ID: 26433845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased cutaneous T-cell-attracting chemokine levels in sera from patients with systemic sclerosis.
    Hayakawa I; Hasegawa M; Matsushita T; Yanaba K; Kodera M; Komura K; Takehara K; Sato S
    Rheumatology (Oxford); 2005 Jul; 44(7):873-8. PubMed ID: 15797972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (2S)-2′-methoxykurarinone from Sophora flavescens suppresses cutaneous T cell-attracting chemokine/CCL27 expression induced by interleukin-ß/tumor necrosis factor-α via heme oxygenase-1 in human keratinocytes.
    Jeong SI; Lee YE; Jang SI
    J Med Food; 2010 Oct; 13(5):1116-24. PubMed ID: 20883179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined With Phototherapy in Advanced Stage Mycosis Fungoides.
    Walker CJ; Espinosa ML; Mehta-Shah N; Pro B; Guitart J; Kuzel T
    J Drugs Dermatol; 2021 Mar; 20(3):349-350. PubMed ID: 33683074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCL27 is downregulated by interferon gamma via epidermal growth factor receptor in normal human epidermal keratinocytes.
    Karakawa M; Komine M; Hanakawa Y; Tsuda H; Sayama K; Tamaki K; Ohtsuki M
    J Cell Physiol; 2014 Dec; 229(12):1935-45. PubMed ID: 24710735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.
    Hijnen D; De Bruin-Weller M; Oosting B; Lebre C; De Jong E; Bruijnzeel-Koomen C; Knol E
    J Allergy Clin Immunol; 2004 Feb; 113(2):334-40. PubMed ID: 14767451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term experience with low-dose interferon-alpha and PUVA in the management of early mycosis fungoides.
    Rupoli S; Goteri G; Pulini S; Filosa A; Tassetti A; Offidani M; Filosa G; Mozzicafreddo G; Giacchetti A; Brandozzi G; Cataldi I; Barulli S; Ranaldi R; Scortechini AR; Capretti R; Fabris G; Leoni P;
    Eur J Haematol; 2005 Aug; 75(2):136-45. PubMed ID: 16000130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phototherapy of Mycosis Fungoides.
    Hodak E; Pavlovsky L
    Dermatol Clin; 2015 Oct; 33(4):697-702. PubMed ID: 26433842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycosis fungoides and Sezary syndrome: therapeutic approach and outcome in 113 patients.
    Anadolu RY; Birol A; Sanli H; Erdem C; Türsen U
    Int J Dermatol; 2005 Jul; 44(7):559-65. PubMed ID: 15985024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of mycosis fungoides with bexarotene and psoralen plus ultraviolet A.
    Coors EA; Von den Driesch P
    Br J Dermatol; 2005 Jun; 152(6):1379-81. PubMed ID: 15949024
    [No Abstract]   [Full Text] [Related]  

  • 32. Prognosis in early stage cutaneous T-cell lymphoma treated with psoralen plus ultraviolet A irradiation and low-dose interferon-α: Long-term efficacy and survival according to conventional and emerging clinical endpoints.
    Rupoli S; Goteri G; Morsia E; Torre E; Giantomassi F; Campanati A; Offidani AM; Molinelli E; Brandozzi G; Serresi S; Giacchetti A; Bugatti L; Filosa G; Mozzicafreddo G; Simonacci M; Olivieri A
    Dermatol Ther; 2022 Oct; 35(10):e15737. PubMed ID: 35903895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does adjuvant alpha-interferon improve outcome when combined with total skin irradiation for mycosis fungoides?
    Roberge D; Muanza T; Blake G; Shustik C; Vuong T; Freeman CR
    Br J Dermatol; 2007 Jan; 156(1):57-61. PubMed ID: 17199567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maintenance phase in psoralen-ultraviolet A phototherapy of early-stage mycosis fungoides. A critically appraised topic.
    Grandi V; Delfino C; Pileri A; Pimpinelli N
    Br J Dermatol; 2017 Aug; 177(2):406-410. PubMed ID: 28078669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations of serum Th1 and Th2 chemokines by combination therapy of interferon-gamma and narrowband UVB in patients with mycosis fungoides.
    Shimauchi T; Sugita K; Nishio D; Isoda H; Abe S; Yamada Y; Hino R; Ogata M; Kabashima K; Tokura Y
    J Dermatol Sci; 2008 Jun; 50(3):217-25. PubMed ID: 18243665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II trial of interferon-alpha-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma.
    Chiarion-Sileni V; Bononi A; Fornasa CV; Soraru M; Alaibac M; Ferrazzi E; Redelotti R; Peserico A; Monfardini S; Salvagno L
    Cancer; 2002 Aug; 95(3):569-75. PubMed ID: 12209749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma.
    Roenigk HH; Kuzel TM; Skoutelis AP; Springer E; Yu G; Caro W; Gilyon K; Variakojis D; Kaul K; Bunn PA
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):198S-205S. PubMed ID: 2258636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CTACK/CCL27 accelerates skin regeneration via accumulation of bone marrow-derived keratinocytes.
    Inokuma D; Abe R; Fujita Y; Sasaki M; Shibaki A; Nakamura H; McMillan JR; Shimizu T; Shimizu H
    Stem Cells; 2006 Dec; 24(12):2810-6. PubMed ID: 16931770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bath-PUVA therapy decreases infiltrating CCR4-expressing tumor cells and regulatory T cells in patients with mycosis Fungoides.
    Kato H; Saito C; Ito E; Furuhashi T; Nishida E; Ishida T; Ueda R; Inagaki H; Morita A
    Clin Lymphoma Myeloma Leuk; 2013 Jun; 13(3):273-80. PubMed ID: 23332394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microarray analysis of gene expression by microdissected epidermis and dermis in mycosis fungoides and adult T-cell leukemia/lymphoma.
    Hashikawa K; Yasumoto S; Nakashima K; Arakawa F; Kiyasu J; Kimura Y; Saruta H; Nakama T; Yasuda K; Tashiro K; Kuhara S; Hashimoto T; Ohshima K
    Int J Oncol; 2014 Sep; 45(3):1200-8. PubMed ID: 24970722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.